UBS AG (USA) (NYSE:UBS)

investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, CenturyLink, Cisco, FireEye, Infoblox, More

Earnings season is winding down, the markets are trying to get past a rough start to 2014, and analysts and investors alike are trying to adjust their expectations for the ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: BofA, Micron, Starbucks, Twitter and More

We are halfway through the first full week of trading in 2014. Analysts are out in droves with many ratings changes this week, and some stocks have managed to pull ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Investors are having to deal with seeing stocks hit new highs almost daily now. With a temporary deal in Washington, D.C., and with earnings coming on strong, investors are caught ...
Read Full Story »
construction

UBS Updates and Adds Top Stocks to the Alpha Preference List

Alpha is one of those confusing terms that is used in the financial industry but rarely defined. It is basically a performance measurement on a risk-adjusted basis. Alpha takes the ...
Read Full Story »
social media network

UBS Top Stocks to Buy for a New Global Economy

Huge increases in productivity from leaps in technology are continuing to shape the way global growth is expanding. New technologies such as 3D printing, advanced robotics, mobile technology and cloud ...
Read Full Story »
Ford Mustang Logo

UBS High Conviction Calls Stocks to Buy With Top Dividend Growth

All of the Wall Street firms we cover, especially the large bulge bracket firms, have an extensive equity coverage list. In many cases the large firms cover more than 500 ...
Read Full Story »
100267991

UBS Lists Top REIT Stocks to Buy for High Dividends

When the Real Estate Investment Trust (REIT) analysts at UBS A.G. (NYSE: UBS) launched their U.S Select REIT portfolio, the idea was to have a flexible portfolio that could be ...
Read Full Story »
NYSE-flag

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

With the equity markets seemingly hitting new all-time highs every day, we were intrigued by the makeup of the new UBS A.G. (NYSE: UBS) Equity Focus List. The analysts incorporate ...
Read Full Story »
Ford Mustang Logo

UBS Top Stocks to Buy That Can Beat Earnings Estimates

The equity analysts and strategists at UBS A.G. (NYSE: UBS) expect to see U.S. equities continue to conform largely to the "1994 Playbook" in which stocks meander higher after correcting ...
Read Full Story »
Online shopping

UBS Positive on Select Internet and Interactive Gaming Stocks

It should come as no surprise to investors that Internet usage has skyrocketed in the past 10 years. The smartphone, which seemed like a luxury five years ago, has become ...
Read Full Story »
131772836

UBS Dividend Ruler Stocks to Buy for the Rest of 2013: Intel, Medtronic and Others

Corporate America continues to increase cash payouts to shareholders at a high, shareholder-friendly rate. S&P 500 dividends per share growth accelerated to 15.5% in the second quarter. That was well ...
Read Full Story »
Apache Block III Ceremony and First Flight

Aerospace and Defense Stocks to Buy That May Dodge Government Cuts

The stock and bond markets are anticipatory. Witness the sharp rise in interest rates when the Federal Reserve has not even tapered its bond buying program, let alone raised key ...
Read Full Story »
95992888

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with the stocks that the top firms feel have the most ...
Read Full Story »
Bank

New Credit Rating for Banks: S&P Downgrades Barclays, Deutsche Bank and Credit Suisse

S&P must believe that a new credit crisis is on the way, or at least there is a reasonably good chance there could be. It hit several of the world's ...
Read Full Story »
biotech

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

On Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company ...
Read Full Story »